Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03556891 · ClinicalTrials.gov registry record · NA
Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence
A NA study, sponsored by Valencia Technologies Corporation.
- Completed
- Registry status
- NA
- Development phase
- 133
- Enrollment target
NCT03556891: Completed NA study, sponsored by Valencia Technologies Corporation.
NCT03556891 is a NA study that has completed, run by Valencia Technologies Corporation. The registered enrollment target is 133 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03556891, a NA study, has completed, sponsored by Valencia Technologies Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 133 participants
- Enrollment target
Study Summary
This trial is a prospective, multicenter, single-arm study of the safety and effectiveness of eCoinTM tibial nerve stimulation in subjects having overactive bladder (OAB) with urgency urinary incontinence (UUI). The study will evaluate changes from baseline in OAB symptoms as measured by voiding diaries and patient reported-outcomes through 48 weeks of eCoinTM therapy or 52 weeks of implantation.
Primary Outcome
Responder rate
Interventions
- DEVICE eCoin Tibial Nerve Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2018-09-04 |
| Est. Completion | 2024-09-18 |
| Phase | NA |
What the finished NCT03556891 record still lists
NCT03556891 is an interventional study that assigns participants to a tested intervention. The registered 133 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which eCoin Tibial Nerve Stimulation is the first listed.
NCT03556891 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03556891 about?
NCT03556891 is a clinical study titled "Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence". This trial is a prospective, multicenter, single-arm study of the safety and effectiveness of eCoinTM tibial nerve stimulation in subjects having overactive bladder (OAB) with urgency urinary incontinence (UUI). The study will evaluate changes from baseline in OAB symptoms as measured by voiding dia...
What is the current status of trial NCT03556891?
This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2018-09-04. Estimated completion is 2024-09-18.
What interventions are being tested in trial NCT03556891?
The interventions under investigation include: eCoin Tibial Nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03556891?
This trial is sponsored by Valencia Technologies Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03556891's enrollment target sits among peer trials
133 729th of 2000 higher than 1,272 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276870 · 133 participants · Phase 2
Orphan Indications for CD19 Redirected Autologous T Cells
- NCT04671771 · 133 participants · NA
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- NCT05610085 · 133 participants · Phase 2
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
- NCT06206486 · 133 participants
The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI